Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
about
Urinary Markers of Tubular Injury in Early Diabetic NephropathyClinical Predictive Factors in Diabetic Kidney Disease ProgressionBiomarkers of Renal Disease and Progression in Patients with DiabetesPredictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes.Diabetic nephropathy - complications and treatment.Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitusUrinary excretion of fatty acid-binding protein 4 is associated with albuminuria and renal dysfunction.Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patientsElevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events.Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating tClinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy.Diagnostic Value of Urine Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Acute Kidney Injury: A Meta-Analysis.Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal FunctionIncreased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study.Urine Injury Biomarkers and Risk of Adverse Outcomes in Recipients of Prevalent Kidney Transplants: The Folic Acid for Vascular Outcome Reduction in Transplantation Trial.Glycopatterns of Urinary Protein as New Potential Diagnosis Indicators for Diabetic Nephropathy.Novel urinary biomarkers in early diabetic kidney disease.Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner.Fatty acid transporting proteins: Roles in brain development, aging, and stroke.Urine liver fatty acid binding protein and chronic kidney disease progression.The association between urinary liver-type fatty acid-binding protein and chronic kidney disease classification in HIV-infected Japanese patients.Urinary liver-type fatty acid binding protein and chronic kidney disease.Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 DiabetesUrine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults.A new pathological scoring system by the Japanese classification to predict renal outcome in diabetic nephropathy.Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus.Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.Efficacy of a Moderately Low Carbohydrate Diet in a 36-Month Observational Study of Japanese Patients with Type 2 Diabetes.
P2860
Q26746921-F2A4E3DD-85C1-44DF-BC62-8D13DD3F4A37Q26749494-C1C3DCFF-60A4-40C3-93A4-C34B6E506C07Q26799505-6102883B-2C9A-4335-9B30-70809905D921Q33817483-DA577C5B-1193-4FD2-A6A3-FDE4520263D2Q34387952-57D0A69F-5EFD-453B-A4F1-6C149B292396Q34644160-B64D7EB5-89BF-44DF-8C24-EB08327DC485Q34704298-F8063FF1-2350-4FF5-AD08-8D866BB46037Q35816851-580EE8CB-350F-41B3-8CEB-37DE2FDD2ADEQ35991042-7FF51CF9-D5A3-4C58-B17F-CE619C591797Q36086582-9362B040-7A93-4818-AAF1-1EE3669314B3Q36106116-91BF8A58-DE39-40FC-A452-82ECA77D01C1Q36255818-ABA2AA37-D6CE-41EA-8CA5-2CD40E1D3D34Q36349400-BEEBCAF8-05BC-4E65-ADE1-E42C4B88D91EQ36844894-FC2B8C2D-4116-4B3C-B2BC-50D36B3C40E0Q36907473-11FE309A-7C4F-4B2E-9256-FF05EB74DC06Q37051993-A0C4A46F-EF71-4CEC-B876-67D875CD9F0BQ37733547-A7F82DD5-1055-4978-9D11-2CC64C7982C9Q38219572-D1ECB2F6-CACE-476F-8944-D192207F3102Q38650405-59746AA4-B1C9-4D3E-AAA1-56FCF6EDE03BQ39273375-3E3DCFD3-E510-4046-8E6A-B4B309B9E050Q40107790-FBACFA0A-E85D-4E0F-80BB-409A362F6694Q40497483-B2B70132-D7E9-42A1-BBAE-3C32C3C5D2E1Q41605584-E4BDD6F6-22A0-4429-B439-B2D902210B7AQ41991255-A22F8028-A09B-4845-B53B-9B2FF68B056EQ46117032-8F0F942E-D40E-44D4-A7F2-254E47EA06D3Q47855701-CD49D3AE-9A44-4DAA-BD44-462BEC302D51Q48097780-A4FB6368-837E-4D61-B8AD-17A22B33199AQ48110750-14A7E14B-A10E-4E43-96B9-316FFD4C486BQ48131003-EBD34DC8-687A-4989-B50B-D8F6CD5EC949Q50950531-B9F4FDA6-DF49-4721-9A4A-A115B254B067Q55386239-299D4350-B590-4EDB-82E4-D917FEE53C0F
P2860
Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Predictive effects of urinary ...... without advanced nephropathy.
@en
type
label
Predictive effects of urinary ...... without advanced nephropathy.
@en
prefLabel
Predictive effects of urinary ...... without advanced nephropathy.
@en
P2093
P2860
P921
P356
P1433
P1476
Predictive effects of urinary ...... without advanced nephropathy.
@en
P2093
Atsunori Kashiwagi
Daisuke Koya
Hiroshi Maegawa
Keiji Isshiki
Masakazu Haneda
Shin-ichi Araki
Shinji Kume
Takashi Uzu
Takeshi Sugaya
P2860
P304
P356
10.2337/DC12-1298
P407
P577
2012-12-05T00:00:00Z